Valuation: Medpace Holdings, Inc.

Market Cap 16.05B 13.94B 12.99B 11.94B 22.58B 1,527B 22.83B 153B 59.89B 763B 60.28B 58.96B 2,529B P/E 2026 *
32.7x
P/E 2027 * 30x
Enterprise Value 15.25B 13.24B 12.35B 11.34B 21.45B 1,451B 21.68B 146B 56.9B 725B 57.27B 56.01B 2,403B EV / Sales 2026 *
5.35x
EV / Sales 2027 * 4.89x
Free-Float
79.98%
Yield 2026 *
-
Yield 2027 * -
1 day+0.31%
1 week+0.72%
Current month-0.35%
1 month+3.13%
3 months+37.90%
6 months+2.41%
Current year+2.39%
1 week 563.45
Extreme 563.45
588.07
1 month 514.47
Extreme 514.47
677.9
Current year 373
Extreme 373
677.9
1 year 373
Extreme 373
677.9
3 years 227.21
Extreme 227.21
677.9
5 years 126.94
Extreme 126.945
677.9
10 years 21.76
Extreme 21.76
677.9
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap.
28/07/26 Sell

Chief Operating Officer

-7,500 0.0263%
28/07/26 Sell

Chief Executive Officer

-3,510 0.0123%
30/06/26 Fiscal year

Director

66 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%+0.72%+32.99%+122.25% 16.05B
-0.43%-3.38%-0.39%+13.30% 48B
+6.03%+5.22%+420.33%+519.87% 41.13B
-2.21%-6.07%+24.87%+5.20% 37.56B
+2.94%-2.25%+6.15%+59.69% 35.91B
+1.98%+4.74%+12.19%+41.37% 29.86B
+0.47%-3.87% - - 16.12B
+0.96%+1.22%+4.32%+18.32% 13.76B
-0.98%-12.98%-4.82%-38.09% 12.1B
-0.07%+0.03%+31.36%-12.27% 11.23B
Average +0.88%-1.62%+58.55%+81.07% 26.17B
Weighted average by Cap. +1.25%-0.89%+80.09%+110.78%

Financials

2026 *2027 *
Net sales 2.85B 2.48B 2.31B 2.12B 4.01B 271B 4.06B 27.22B 10.64B 136B 10.71B 10.47B 449B 3.03B 2.63B 2.45B 2.25B 4.26B 288B 4.3B 28.89B 11.29B 144B 11.37B 11.12B 477B
Net income 503M 436M 407M 374M 707M 47.8B 715M 4.8B 1.88B 23.9B 1.89B 1.85B 79.18B 547M 475M 443M 407M 769M 51.99B 777M 5.22B 2.04B 25.99B 2.05B 2.01B 86.12B
Net Debt -802M -697M -650M -597M -1.13B -76.32B -1.14B -7.66B -2.99B -38.15B -3.01B -2.95B -126B -1.25B -1.09B -1.01B -931M -1.76B -119B -1.78B -11.95B -4.67B -59.54B -4.7B -4.6B -197B
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,500
Date Price Change Volume
04/08/26 $575.08 +0.31% 227,919
03/08/26 $573.29 -0.66% 249,533
31/07/26 $577.11 -0.21% 261,431
30/07/26 $578.30 -1.13% 318,296
29/07/26 $584.93 +2.44% 580,886
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
575.08USD
Average target price
581.83USD
Spread / Average Target
+1.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEDP Stock